| Ident. | Authors (with country if any) | Title |
|---|
| 000087 (2021) |
Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France] | The hydroxychloroquine debate: a therapeutic dilemma for general practitioners. |
| 000106 (2021) |
Abdulkarim Abdulrahman [Bahreïn] ; Islam Alsayed [Bahreïn] ; Marwa Almadhi [Royaume-Uni] ; Jumana Alarayed [Bahreïn] ; Sara Jaafar Mohammed [Bahreïn] ; Aesha Khalid Sharif [Bahreïn] ; Khadija Alansari [Bahreïn] ; Abdulla Ismael Alawadhi [Bahreïn] ; Manaf Alqahtani [Bahreïn] | The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort. |
| 000107 (2021) |
O O Oleribe [Nigeria] ; P. Oskouipour [États-Unis] ; O. Nwanyanwu [États-Unis] ; S D Taylor-Robinson [Royaume-Uni] | The COVID-19 era: the view from Nigeria. |
| 000115 (2021) |
Praveen Kumar-M [Inde] ; Ritin Mohindra [Inde] ; Ashish Bhalla [Inde] ; Nusrat Shafiq [Inde] ; Vikas Suri [Inde] ; Deepa Kumari [Inde] ; Avaneesh Kumar Pandey [Inde] ; Ankur Gupta [Inde] ; Parul Chawla Gupta [Inde] ; Amol Patil [Inde] ; Ashish Kumar Kakkar [Inde] ; Samir Malhotra [Inde] | System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India. |
| 000171 (2021) |
Carmen Manciuc [Roumanie] ; Dragos Nemescu [Roumanie] ; Andrei Vata [Roumanie] ; Georgiana Alexandra Lacatusu [Roumanie] | SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience. |
| 000231 (2021) |
Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis] | Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. |
| 000344 (2021) |
Stephanie J. Stroever [États-Unis] ; Daniel Ostapenko [États-Unis] ; Robyn Scatena [États-Unis] ; Daniel Pusztai [États-Unis] ; Lauren Coritt ; Akua A. Frimpong ; Paul Nee [États-Unis] | Medication Use Among Patients With COVID-19 in a Large, National Dataset: Cerner Real-World Data™. |
| 000545 (2021) |
Majid Haghjoo [Iran] ; Reza Golipra [Iran] ; Jalal Kheirkhah [Iran] ; Allahyar Golabchi [Iran] ; Javad Shahabi [Iran] ; Saeed Oni-Heris [Iran] ; Ramin Sami [Iran] ; Marzieh Tajmirriahi [Iran] ; Mehrdad Saravi [Iran] ; Mozhdeh Khatami [Iran] ; Mehran Varnasseri [Iran] ; Mohammadreza Kiarsi [Iran] ; Seyed Fakhreddin Hejazi [Iran] ; Mojtaba Yousefzadeh Rahaghi [Iran] ; Maryam Taherkhani [Iran] ; Haleh Ashraf [Iran] ; Mohammad Sadegh Keshmiri [Iran] ; Mohammad Ali Akbarzadeh [Iran] ; Ali Bozorgi [Iran] ; Fateme Mottaghizadeh [Iran] ; Behnam Hedayat [Iran] ; Mona Heidarali [Iran] ; Azita Hajhossein Talasaz [Iran] | Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey. |
| 000610 (2021) |
Majid Mokhtari [Iran] ; Minoo Mohraz [Iran] ; Mohammad Mehdi Gouya [Iran] ; Hengameh Namdari Tabar [Iran] ; Jafar-Sadegh Tabrizi [Iran] ; Katayoun Tayeri [Iran] ; Saeide Aghamohamadi [Iran] ; Zahra Rajabpoor [Iran] ; Manoochehr Karami [Iran] ; Alireza Raeisi [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran] | Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. |
| 000640 (2021) |
Ernesto Carafoli [Italie] | Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection. |
| 000644 (2021) |
Sultan A M. Saghir [Jordanie] ; Naif A. Algabri [Yémen, Djibouti] ; Mahmoud M. Alagawany [Égypte] ; Youssef A. Attia [Égypte] ; Salem R. Alyileili [Émirats arabes unis] ; Shaaban S. Elnesr [Égypte] ; Manal E. Shafi ; Omar Y A. Al-Shargi ; Nader Al-Balagi ; Abdullah S. Alwajeeh [Qatar] ; Omar S A. Alsalahi [Yémen] ; Amlan K. Patra [Inde] ; Asmaa F. Khafaga [Égypte] ; Ahmed Negida [Royaume-Uni, Égypte] ; Ahmed Noreldin [Égypte] ; Wesam Al-Amarat [Jordanie] ; Amer A. Almaiman ; Khaled A. El-Tarabily [Émirats arabes unis, Australie] ; Mohamed E. Abd El-Hack [Égypte] | Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review. |
| 000678 (2021) |
Bin Zhou [Japon] ; Shinsuke Kojima [Japon] ; Atsuhiko Kawamoto [Japon] ; Masanori Fukushima [Japon] | COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. |
| 000702 (2021) |
Imad Naasani [Royaume-Uni] | COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics. |
| 000740 (2021) |
Viktorija Dragojevic Simic [Serbie] ; Milijana Miljkovic [Serbie] ; Dusica Stamenkovic [Serbie] ; Berislav Vekic [Serbie] ; Nenad Ratkovic [Serbie] ; Radoje Simic [Serbie] ; Nemanja Rancic [Serbie] | An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine. |
| 000818 (2020) |
Kalyan Kumar Gangopadhyay [Inde] ; Binayak Sinha [Inde] ; Samit Ghosal [Inde] | "Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey". |
| 000903 (2020) |
Mohammed M. Alvi [États-Unis] ; Sowmya Sivasankaran [États-Unis] ; Mahima Singh [États-Unis] | Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19. |
| 000904 (2020) |
Migita D'Cruz [Inde] | The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: Need to interpret with caution. |
| 000906 (2020) |
Dinesh Kumar Badyal [Inde] ; Rajiv Mahajan [Inde] | Chloroquine: Can it be a Novel Drug for COVID-19. |
| 000930 (2020) |
Q. Gao [République populaire de Chine] | [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)]. |
| 000970 (2020) |
Sudhir Mehta [Inde] ; Sudhir Bhandari [Inde] ; Shaurya Mehta [Inde] | Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection? |
| 000A17 (2020) |
Hongjun Miao [République populaire de Chine] ; Han Li [République populaire de Chine] ; Yinying Yao [République populaire de Chine] ; Mingfu Wu [République populaire de Chine] ; Chao Lu [République populaire de Chine] ; Jun Wang [République populaire de Chine] ; Man Tian [République populaire de Chine] ; Ying Li [République populaire de Chine] ; Peiliang Luo [République populaire de Chine] ; Jianhui Gu [République populaire de Chine] ; Bin Yuan [République populaire de Chine] ; Shouchuan Wang [République populaire de Chine] ; Xia Zhao [République populaire de Chine] ; Weihua Gan [République populaire de Chine] ; Deyu Zhao [République populaire de Chine] | Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children. |
